Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,684.20
Bid: 1,680.40
Ask: 1,680.80
Change: 9.20 (0.55%)
Spread: 0.40 (0.02%)
Open: 1,677.40
High: 1,697.00
Low: 1,675.00
Yest. Close: 1,675.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

BROKER RATINGS SUMMARY: UBS Raises Greggs; Peel Hunt Lifts Chesnara

Wed, 28th Aug 2019 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday afternoon and Wednesday morning:



FTSE 100



KEPLER CHEUVREUX RAISES GLAXOSMITHKLINE PRICE TARGET TO 1600 (1540) PENCE - 'HOLD'



JEFFERIES CUTS SPIRAX-SARCO PRICE TARGET TO 7855 (8525) PENCE - 'HOLD'



GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1890 (1680) PENCE - 'SELL'



BARCLAYS CUTS BUNZL PRICE TARGET TO 2400 (2550) PENCE - 'OVERWEIGHT'



INDEPENDENT RESEARCH CUTS BP PRICE TARGET TO 550 (590) PENCE - 'HOLD'



INDEPENDENT RESEARCH CUTS BHP GROUP PRICE TARGET TO 1925 (2100) PENCE - 'HOLD'



JPMORGAN REMOVES BHP FROM EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST



JPMORGAN ADDS GLENCORE TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST



JPMORGAN REMOVES BRITISH AMERICAN TOBACCO FROM EUROPEAN BEST EQUITY OVERWEIGHT IDEAS LIST



JPMORGAN ADDS PEARSON TO EUROPEAN BEST EQUITY OVERWEIGHT IDEAS LIST



JPMORGAN ADDS ADMIRAL TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST



JPMORGAN REMOVES FERGUSON FROM EUROPEAN BEST EQUITY OVERWEIGHT IDEAS-LIST



FTSE 250



UBS RAISES GREGGS TO 'BUY' ('NEUTRAL') - TARGET 2300 (1880) PENCE



UBS RAISES POLYMETAL PRICE TARGET TO 1300 (1200) PENCE - 'BUY'



GOLDMAN RAISES POLYMETAL PRICE TARGET TO 1310 (1300) PENCE - 'BUY'



JPMORGAN CUTS PLAYTECH PRICE TARGET TO 585 (603) PENCE - 'OVERWEIGHT'



JPMORGAN ADDS JOHN WOOD GROUP TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS-LIST



RBC CUTS JOHN WOOD GROUP PRICE TARGET TO 600 (670) PENCE - 'OUTPERFORM'



JEFFERIES RAISES DIPLOMA PRICE TARGET TO 1800 (1790) PENCE - 'BUY'



OTHER MAIN MARKET AND AIM



PEEL HUNT RAISES CHESNARA TO 'HOLD' ('REDUCE')



JPMORGAN RAISES DAILY MAIL PRICE TARGET TO 950 (870) PENCE - 'OVERWEIGHT'



BARCLAYS CUTS KINGSPAN GROUP PRICE TARGET TO 4100 (4500) PENCE - 'EQUAL WEIGHT'



More News

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

Today 11:06

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

Today 09:23

UPDATE 1-FTSE falters as Brexit hopes lift pound; domestic stocks rejoice

* FTSE 100 down 0.3%, FTSE 250 up 0.8%* Brexit deal hopes lift sterling, hit exporters* Housebuilders, UK banks jump* WPP, Burberry fall after European rivals cut forecast* Dart Group climbs higher after hiking profit view (Adds news items, analyst ...

11 Oct 19 09:07

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

* FTSE 100 up 0.1%, FTSE 250 down 0.1%* GVC gains after forecast upgrade* Just Eat tops blue-chip risersBy Muvija M and Shashwat AwasthiOct 9 (Reuters) - London's exporter-laden FTSE 100 lagged its European peers on Wednesday, as sterling gained on ...

9 Oct 19 10:21

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

(Adds context on U.S. FDA move)Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.The mo...

8 Oct 19 16:53

UPDATE 2-GSK recalls prescription-only versions of heartburn drug Zantac

* Four products recalled; over-the-counter ones not affected* UK regulator says recall a "precautionary measure"* Regulators investigating ranitidine drugs for impurities (Adds details on products affected, context on other drugmakers halting suppl...

8 Oct 19 16:53

UPDATE 3-GSK recalls popular heartburn drug Zantac globally after cancer scare

* GSK recalls Zantac products in all markets as a "precaution"* Four products recalled; OTC ones not affected -UK regulator* GSK says working with regulators to address concerns (Tweaks headline, first paragraph; adds company comment)By Justin Geo...

8 Oct 19 16:53

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

8 Oct 19 16:33

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.GSK is recalling all unexpired stock ...

8 Oct 19 16:25

UPDATE 2-Trade hopes lift FTSE 100, SIG drags down mid-caps

* FTSE 100 up 0.6%, FTSE 250 dips 0.3%* Hopes for U.S.-China deal help blue-chips* Mid-cap SIG plummets after profit warning (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 7 (Reuters) - Oil majors led a rebound in ...

7 Oct 19 09:29

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

4 Oct 19 17:31

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

4 Oct 19 14:24

FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

Oct 4 (Reuters) - British drugmaker AstraZeneca said on Friday that the U.S. Food and Drug Administration (FDA) has approved self-administration of its asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.The move is a bo...

4 Oct 19 08:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

3 Oct 19 16:04

UPDATE 1-AstraZeneca's combo lung disease therapy fails to win FDA approval

(Adds details on treatment, context and background)Oct 1 (Reuters) - The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.AstraZeneca said that it will...

1 Oct 19 07:43

Login to your account

Don't have an account? Click here to register.